Atossa Therapeutics
ATOS
#10540
Rank
NZ$33.17 M
Marketcap
NZ$3.33
Share price
6.21%
Change (1 day)
142.98%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: NZ$33.17 Million

As of June 2026 Atossa Therapeutics has a market cap of NZ$33.17 Million. This makes Atossa Therapeutics the world's 10540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$33.17 M-77.43%
2025NZ$0.14 B-32.85%
2024NZ$0.21 B25.51%
2023NZ$0.17 B65.42%
2022NZ$0.10 B-64.46%
2021NZ$0.29 B373.79%
2020NZ$62.6 M194.11%
2019NZ$21.28 M139.42%
2018NZ$8.89 M-24.56%
2017NZ$11.78 M52.84%
2016NZ$7.71 M-49.5%
2015NZ$15.26 M-65.94%
2014NZ$44.83 M-14.51%
2013NZ$52.43 M-14.38%
2012NZ$61.24 M

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Atossa Therapeutics was reported to be:

NZ$28.63 Million
by Nasdaq info icon info icon
NZ$33.17 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.084 T 3,268,827.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$41.09 B 123,789.38%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$39.37 B 118,603.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$4.99 B 14,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$3.26 B 9,738.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$64.72 M 95.10%๐Ÿ‡บ๐Ÿ‡ธ USA